Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections

By Baumann U.   Mansouri E.   von Specht B.-U.  

Vaccine, Vol. 22, Iss. 7, 2004-02 ,pp. : 840-847

Elsevier

Access to resources Recommend Favorite

Correlations between saliva protein composition and some T-I parameters of astringency

By Kallithraka S.   Bakker J.   Clifford M.N.   Vallis L.  

Food Quality and Preference, Vol. 12, Iss. 2, 2001-03 ,pp. : 145-152

Elsevier

Access to resources Recommend Favorite

Identification of CD4 + T cell epitopes on the fusion (F) and attachment (G) proteins of bovine respiratory syncytial virus (BRSV)

By Fogg M.H.   Parsons K.R.   Thomas L.H.   Taylor G.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3226-3240

Elsevier

Access to resources Recommend Favorite

New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clones

By Begum N.   Horiuchi S.   Tanaka Y.   Yamamoto N.   Ichiyama K.   Yamamoto N.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1281-1289

Elsevier

Access to resources Recommend Favorite

Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens

By Reimann J.   Schirmbeck R.   Deml L.   Melber K.   Wolf H.   Wagner R.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 857-865

Elsevier

Access to resources Recommend Favorite